Stoke Therapeutics Inc (STOK) — Financial Flexibility Index
Stoke Therapeutics Inc (STOK) has a Financial Flexibility Index of -1.24x as of March 2026. Free cash flow of $-60.23 Million (operating CF $-60.58 Million minus capex $353.00K) represents -1% of total liabilities ($48.40 Million). Also explore STOK year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Stoke Therapeutics Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Stoke Therapeutics Inc across 9 annual periods. Check Stoke Therapeutics Inc (STOK) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Stoke Therapeutics Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Stoke Therapeutics Inc. For the full company profile including market capitalisation, see Stoke Therapeutics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.70x | $46.26 Million | $45.59 Million | $65.98 Million | ▲ +134.4% |
| 2024 | -2.04x | $-86.65 Million | $-86.85 Million | $42.53 Million | ▼ -76.3% |
| 2023 | -1.16x | $-79.45 Million | $-81.07 Million | $68.78 Million | ▼ -194.8% |
| 2022 | -0.39x | $-27.90 Million | $-31.87 Million | $71.22 Million | ▲ +87.4% |
| 2021 | -3.12x | $-65.71 Million | $-66.91 Million | $21.09 Million | ▲ +10.3% |
| 2020 | -3.48x | $-41.17 Million | $-42.22 Million | $11.85 Million | ▲ +48.9% |
| 2019 | -6.81x | $-29.42 Million | $-31.05 Million | $4.32 Million | ▼ -67.7% |
| 2018 | -4.06x | $-10.03 Million | $-10.96 Million | $2.47 Million | ▼ -187.3% |
| 2017 | -1.41x | $-5.27 Million | $-5.38 Million | $3.73 Million | — |